APA (7th ed.) Citation

Vergis, N., Phillips, R., Cornelius, V., Katsarou, A., Youngstein, T., Cook, L., . . . Cooper, N. (2021). Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: A structured summary of a study protocol for a randomised controlled trial. Trials, 22(1), 1. https://doi.org/10.1186/s13063-021-05190-z

Chicago Style (17th ed.) Citation

Vergis, Nikhil, et al. "Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-021-05190-z.

MLA (9th ed.) Citation

Vergis, Nikhil, et al. "Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-021-05190-z.